Thursday, November 30, 2023
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home SCIENCE NEWS Cancer

New drug combination shows promise for resistant leukemia

May 18, 2016
in Cancer
0
Share on FacebookShare on Twitter
IMAGE

Credit: The Walter and Eliza Hall Institute of Medical Research

Patients with acute myeloid leukaemia (AML) can look forward to the development of new therapies following the discovery by Walter and Eliza Hall Institute researchers of a new way to kill cells that are dangerously multiplying.

A process known as apoptosis (programmed cell death) — which is a natural and necessary response to keep the proliferation of human cells in check — is interrupted in cancers, including AML, leading to unchecked cell growth.

Institute researcher Dr Gabriela Brumatti and her PhD student Chunyan Ma are part of a team, led by Professor John Silke from the Institute and Professor Paul Ekert from the Murdoch Childrens Research Institute in Melbourne, investigating ways to target particular types of AML, hoping to increase the chance of a cure for the patient while limiting damage to healthy cells.

Dr Brumatti said traditional chemotherapies, which induce apoptosis, had a high relapse rate. For example, within five years of completing treatment 50 per cent of AML patients suffer a relapse of their cancer. Of those who relapse, only 50 per cent survive.

Her team tried a 'blue sky' approach to their research and inhibited apoptosis of AML cells in order to unleash an alternative form of cell death called necroptosis. They found this necroptosis cell death pathway was more effective at killing AML than apoptosis. These findings have just been published in the research journal, Science Translational Medicine.

In preclinical trials they used a combination of drugs — birinapant, a new anti-cancer drug, and emricasan, a US Food and Drug Administration (FDA) approved inhibitor of apoptosis — to kill AML.

"It has been speculated that inducing necroptosis might be an effective way to kill cancer cells", said Professor Silke. "Our work now demonstrates clearly it is a clinically feasible and safe approach."

Dr Brumatti said since cancer cells often acquire resistance to traditional chemotherapy-induced apoptosis, this novel type of chemotherapy had the potential to be used to treat otherwise impossible to treat leukaemias.

###

This work was supported by a grant from the Leukemia & Lymphoma Society, the National Health and Medical Research Council (NHMRC), and an Association pour le Recherche contre le Cancer (ARC) fellowship with additional support from the Australian Cancer Research Foundation, the Victorian State Government Operational Infrastructure Support, and the NHMRC Independent Research Institutes Infrastructure Support Scheme.

Media Contact

Ebru Yaman
ebru.yaman@wehi.edu.au
042-803-4089
@WEHI_research

http://www.wehi.edu.au/

Share25Tweet16Share4ShareSendShare
  • Ohio State receives $14 million to study optimal aspirin therapy in pregnancy

    68 shares
    Share 27 Tweet 17
  • Scientists discover rare 6-planet system that moves in strange synchrony

    67 shares
    Share 27 Tweet 17
  • AI image generator Stable Diffusion perpetuates racial and gendered stereotypes, study finds

    66 shares
    Share 26 Tweet 17
  • ‘Team Waponi’ advances to finals of $10M XPRIZE Rainforest Competition with ‘Limelight’, earns $300K semi-finalist prize

    68 shares
    Share 27 Tweet 17
  • The dangers of being a saber-toothed cat in Los Angeles 12,000 years ago

    88 shares
    Share 35 Tweet 22
  • ‘Dolomite Problem’: 200-year-old geology mystery resolved

    68 shares
    Share 27 Tweet 17
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

Collaboration between women helps close the gender gap in ice core science

“Amaterasu” particle: a new cosmic mystery

Alcohol consumption and epigenetic age acceleration across human adulthood

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 208 other subscribers

© 2023 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2023 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In